Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework.
Saved in:
| Title: | Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework. |
|---|---|
| Authors: | Wolters, E. E.1,2 (AUTHOR) e.e.wolters-2@umcutrecht.nl, Dodich, A.3,4 (AUTHOR), Boccardi, M.5 (AUTHOR), Corre, J.3,6 (AUTHOR), Drzezga, A.7,8,9 (AUTHOR), Hansson, O.10,11 (AUTHOR), Nordberg, A.12 (AUTHOR), Frisoni, G. B.13,14 (AUTHOR), Garibotto, V.3 (AUTHOR), Ossenkoppele, R.2,11 (AUTHOR) |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Jul2021, Vol. 48 Issue 7, p2097-2109. 13p. 1 Diagram. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
